...
首页> 外文期刊>Renal failure. >Identification of crucial miRNAs and the targets in renal cortex of hypertensive patients by expression profiles
【24h】

Identification of crucial miRNAs and the targets in renal cortex of hypertensive patients by expression profiles

机译:通过表达谱鉴定高血压患者肾皮质中的关键miRNA和靶标

获取原文

摘要

Abstract Backgrounds: Defect in kidney is one major reason of hypertension. The study aimed ao uncovering the regulatory mechanisms of miRNAs and the targets in hypertensive kidney. Methods: Gene expression profile of GSE28345 and miRNA expression profile of GSE28283 were downloaded from GEO database. After data preprocessing, differently expressed genes (DEGs) and miRNAs (DE-miRs) were identified using limma package. Then targets of miRNAs were predicted according to information in relevant databases. Function and pathway enrichment analyses were performed for DEGs using DAVID software. Furthermore, protein–protein interaction (PPI) networks were constructed for up- and down-regulated genes, respectively, using the Cytoscape. Additionally, for down-regulated DEGs, the integrated regulatory network was established combining PPI network with the miRNA–mRNA interactions. Results: As a result, 285 DEGs were identified, including 177 up-regulated and 108 down-regulated genes. Combined with the predicted targets of miRNAs, 22 up-regulated DE-miRs were identified. In the integrated network for down-regulated DEGs, three crucial nodes were identified as ASPN, COL12A1, and SCN2A. ASPN was predicted as target of miR-21 and miR-374b, and COL12A1 was the target of miR-30e, miR-21, and miR-195, while SCN2A was the target of miR-30e, miR-374b, and miR-195. Notably, COL12A1 and ASPN were linked with each other in the network. Conclusion: Three crucial genes were identified in hypertensive kidney, such as COL12A1, ASPN, and SCN2A. ASPN might co-function with COL12A1, and they both might be the targets of miR-21. SCN2A might be a novel target of miR-30e and miR-374b. However, more experiments are needed to validate these results.
机译:摘要背景:肾脏缺陷是高血压的主要原因之一。该研究旨在揭示miRNA的调控机制和高血压肾脏中的靶标。方法:从GEO数据库下载GSE28345的基因表达谱和GSE28283的miRNA表达谱。经过数据预处理后,使用limma软件包识别了差异表达的基因(DEG)和miRNA(DE-miRs)。然后根据相关数据库中的信息预测miRNA的靶标。使用DAVID软件对DEG进行功能和途径富集分析。此外,使用Cytoscape分别为上调和下调的基因构建了蛋白质-蛋白质相互作用(PPI)网络。此外,对于下调的DEG,建立了将PPI网络与miRNA-mRNA相互作用相结合的集成调控网络。结果:结果,鉴定出285个DEG,包括177个上调基因和108个下调基因。结合预测的miRNA靶标,鉴定出22个上调的DE-miR。在用于下调DEG的集成网络中,三个关键节点被标识为ASPN,COL12A1和SCN2A。预计ASPN是miR-21和miR-374b的靶标,而COL12A1是miR-30e,miR-21和miR-195的靶标,而SCN2A是miR-30e,miR-374b和miR- 195。值得注意的是,COL12A1和ASPN在网络中相互链接。结论:在高血压肾脏中鉴定出三个关键基因,如COL12A1,ASPN和SCN2A。 ASPN可能与COL12A1协同工作,它们都可能是miR-21的靶标。 SCN2A可能是miR-30e和miR-374b的新型靶标。但是,需要更多的实验来验证这些结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号